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Red  cells  coated  with  IgG  globulin  are  bound  circumferentially  about  a 
central mononuclear cell or monocyte into  a  "rosette"  (1).  Attached red cells 
appear  deformed and  closely resemble  the  abnormal red  cell  morphology fre- 
quently  observed  in  the  peripheral  blood  of  patients  with  Coombs  positive 
hemolytic  anemia  associated  with  IgG  antibodies.  Although  in  some  studies 
the  monocyte  receptor  was  specific  for  IgG  globulin  without  specificity  for 
the  third  component of  complement  (C3)  (1,  2),  in  others  a  receptor  for C3 
(3, 4)  as well as a nonspecific receptor (5) have been described. We report here 
confirmation of the IgG specificity of the mononuclear cell receptor for rosette 
formation. A  C3 receptor for rosette formation was not observed. 
Some  of  the  well  described  biologic  functions  of  the  Fc  fragment  of  IgG 
globulin reside in selective IgG subclasses (6). IgG subclass specificity for rosette 
formation is described  in  this  report in addition to studies which further delin- 
eate the peptide portion  of the  Fc fragment  of IgG that binds  to  the  mono- 
cyte.  1 
Materials and Methods 
Proteins.--Sera containing  high  titers  of anti-D  were obtained  from patients  with  Rh 
incompatibility as a result of pregnancy and from one individual previously immunized. These 
anti-D  antibodies were warm-active IgG globulins. Sera containing cold agglutinins  (anti-l) 
were derived from patients  who had mycoplasma pneumonia or from individuals with "idio- 
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pathic" cold agglutinin hemolytic anemia. Anti-Duffy, anti-Kidd, and anti-H isoantibodies 
were kindly provided.  2 IgG subclasses were purified from the sera of patients with multiple 
myeloma.  3 Purified heavy chains (3,14 and "/36), purified from the urine of patients with heavy 
chain disease,  were provided. T4 heavy chain was isolated from the pleural fluid of a patient 
with heavy chain disease. 5 In order to obtain fragments of IgG, IgG was first isolated from 
Cohn fraction II  by elution from DEAE-cellulose with 0.007  ~  phosphate buffer, pH 6.3. 
Purified IgG was then reacted with cysteine-activated 1%  papain according to previously 
described methods (7). CM Sephadex chromatography was carried out with step-wise elutions 
from 0.01 ~  phosphate, pH  7.6, to 0.4 ~  NaC1-0.01  ~  phosphate, in order to separate Fc 
fragment contained in the first eluate from Fab fragment which was eluted in a late peak. Fc 
was separated from residual intact papain-resistant IgG by gel filtration (Sephadex G-100). 
The purity of the preparations was confirmed by immunoelectrophoresis using monospecific 
antibody (8) and by ultracentrifugation. 
Reduction of Fc or heavy chains was carried out by reaction with 0.05 ~  dithiothreitol 
(DTT) 6 in 8 M urea  0.2  ~  tris (hydroxymethyl) amino-methane (Tris)-chloride buffer,  pH 
8.2 at 37°C for 4 hr. The reaction was completed by alkylation with 1.5 ~ excess iodoacetamide 
and dialysis against saline for 48 hr. Purified Fc and heavy chains were also treated with 8 
urea alone at 37°C for 4 hr followed by dialysis against saline for 48 hr. F(ab')2 was prepared 
according to the methods of Nisonoff et al.  (9). Pepsin components II, III, and IV were pro- 
duced by the digestion of purified IgG with 2% pepsin (10) and were separated by gel filtration 
(Sephadex G-75).  Human serum albumin was obtained commercially.  7 Purified C3 was pre- 
pared from normal serum (11) and stored at -70°C. 
Cells.--As previously described (12), white cells were obtained from heparinized peripheral 
blood by dextran sedimentation, light centrifugation, and resuspension of the cell button in 
Hanks' balanced salt solution  (containing 5  X  10  -4 ~  MgC12 and  1.3  X  10  -3 ~  CaC12).  s 
Red ceils which were obtained from human blood (anticoagulated with heparin or acid-citrate- 
dextrose  9)  were trace-radiolabeled with Na~51CrO4  (50-150  #Ci/ml whole blood) according 
to standard techniques (13). 
Attachment of Protein to Red Cells.--Red cells were washed with 80-100 volumes of Hanks' 
and brought to a 50% hematocrit. Equal volumes of these washed red cells and serum antibody 
(warm-type) were incubated for  1 hr at 37°C,  after which they were rewashed in Hanks'. 
Purified proteins were also coupled to red cells nonspecifically using chromic chloride (14). 
In this method, as previously described (12), a mixture was made of one part red cells  (de- 
fibrinated blood washed six times with saline)  at a 50% hematocrit, five parts of a protein 
solution (1 g/100 ml of saline), and two parts of chromic chloride (Cr  +++)  in saline (5 #moles 
Cr+++/ml of packed red cells for the coupling of mixed IgG or IgG subclasses). The Cr  +++ 
solution was added last. After 4  rain at room temperature, the reaction was terminated by 
four saline washes. C3 was placed on red cells by two methods. In the first, 0.1 ml of washed 
normal red cells at a 4% hematocrit was incubated with 0.05 ml of fresh serum and 0.15 ml 
of serially diluted anti-Duffy or anti-Kidd antibody at 37°C for 2 hr, or with anti-H or anti-I 
antibody at 4°C  overnight. After the initial incubation at either 37 ° or 4°C, the cells were 
washed and incubated in Hanks' at 37°C for 2 hr. Secondly,  C3 was placed onto red cells in 
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low ionic strength  sucrose as previously described  (15).  Detection of red cell coating with 
immunoglobulin or C3  was performed by Coombs testing with monospecific  antisera  (16). 
Incubation Technique.--To  a vinyl cup 1° (~/~ inch diameter), 0.4 ml of the white cell sus- 
pension (10,000-20,000  white blood cells/mm  3) and 0.1 ml of Hanks' were added. After 45 min 
at 24°C the attached monolayer was rinsed with four washes of Hanks'. Test red cells (0.4 ml 
of a 5% hematocrit)  and  0.1  ml of Hanks' were layered over the white cell monolayer. For 
rosette-inhibition experiments, 0.1 ml of the test protein was added in place of Hanks'. After 
2  hr  at  24°C  unattached  red  cells were  removed  by four washes with  Hanks'.  Rosette 
formation or red cell binding was determined by light microscopy on wet preparations or after 
staining with Wright's solution. Quantitation of red cell binding was obtained by the release 
of radiolabeled hemoglobin after water lysis. For rosette-inhibition experiments, per cent in- 
hibition was calculated as 100% minus the per cent uptake which occurred in the presence of 
test protein.  Red cell adherance to monolayers which occurred in the absence of inhibiting 
protein was assumed to be 100% uptake. 
TABLE  I 
Per  Cent Inhibition  of Rosette Formation 
10 rag/100  14 rag/100  25 rag/100  50 rag/100  Free protein  2 rag/100 ml  5 mg/100 ml  ml  ml  ml  ml 
IgG mixed  89.5  88.7  84.2  97.0  96.8  93.5 
IgG1  68.6  87.4  80.4  95.3  93.8  92.1 
IgG2  10.6  23.6  21.6  49.1  74.1  32.4 
IgG3  90.9  86.0  90.8  96.8  93.1  94.8 
IgG4  29.7  61.0  40.1  86.0  80.4  85.9 
Albumin  0  0  0  0  0  0 
None  0  0  0  0  0  0 
Rosette inhibition of anti-D-coated red ceils. Mixed (normal)  IgG, IgG subclasses purified 
from the sera of patients with myeloma, and  albumin were used at final concentrations which 
varied from 2 mg/100 ml to 50 mg/100 ml. Per cent inhibition  equaled 100%  minus the per 
cent uptake. The binding which occurred in the absence  of protein was  assumed to be 100% 
uptake. 
RESULTS 
Subclass  Specificity.--Rosette-inhibition  experiments  were  performed  with 
anti-D-coated  51Cr-labeled  red cells and free  purified myeloma IgG subclasses 
(Table I). The final concentration  of inhibiting protein was  varied from 2 mg/ 
100  ml  to  50  rag/100  ml.  Mixed  IgG  was  obtained  from  normal  serum  and 
presumably  was  comprised  of  the  four  IgG  subc]asses  in  physiologic  ratio. 
Mixed IgG inhibited rosette formation  at  all concentrations,  whereas  albumin 
resulted  in  no  inhibition.  IgG1  and  IgG3  were  effective inhibitors;  IgG8  was 
slightly more inhibitory especially at  the lowest concentration  (2 mg/100 ml). 
IgG2  possessed  the  least  inhibitory  activity  at  the  lower  concentrations  (2 
rag/100  ml-10  rag/100  ml)  and  IgG4  was  intermediate  in  inhibitory  effect. 
In order to test for variation  within  an individua]  IgG subclass,  purified IgG1 
10 Fabrikal Corp.,  Kalamazoo, Mich. 1210  INTERACTION  BETWEEN HUMAN MONOCYTES AND RED  CELLS 
from six different patients with IgG1 myeloma were studied in rosette-inhibition 
experiments  at  a  final  concentration  of  10  rag/100  ml.  Rosette  inhibition 
ranged from 71.1  to 82 % for the four kappa chain-specific myelomas and from 
80.7 to 89.4% with the two lambda chain-specific proteins. 
Heavy  chains  isolated  from  patients  with  heavy  chain  disease  were  also 
studied  in  rosette-inhibition experiments.  3"1  and  3"3  heavy  chains  inhibited 
rosette formation but 3"4 heavy chain had less inhibition (Table II). 
TABLE  II 
Final  protein  Per cent 
IgG fragment  concentration  inhibition 
(mg/lO0 tel) 
Fc  10  91.6 
Fab  10  0 
F(ab')  2  10  15.0 
Pepsin component II  10  0 
Pepsin component III  10  0 
Pepsin component IV  10  0 
Fc--untreated  10 
Fc--8 ~t urea  10 
Fc--DTT in 8 ~I urea  10 
3'1 Heavy chain (Cra)*--untreated  25 
3`1 Heavy chain (Cra)*--8 ~t urea  25 
3'1 Heavy chain (Cra)*--DTT in 8 ~ urea  25 
Fc  12 
3"1 Heavy chain (Cra)*  12 
3"3 Heavy chain (Raf)*  12 
3"4 Heavy chain (Hall)*  12 
93.6 
90.4 
0 
86.6 
95.4 
30.8 
87.4 
82.6 
61.0 
38.2 
Rosette inhibition  of anti-D-coated cells by fragments of IgG globulin. Per cent inhibition 
equaled 100% minus the per cent uptake. Binding which occurred in the absence of inhibiting 
protein was designated at 100% uptake. 
* From heavy chain disease. 
Specificity of binding within the IgG subclass was also studied by measuring 
the binding to monolayers of red cells coupled with purified IgG subclasses by 
means of chromic chloride. The coupling of protein to red cells was confirmed 
by Coombs testing with purified subclass antisera,  n Red cell binding to leuko- 
cyte monolayers was  quantitated (Fig.  1)  using Na251CrO4-1abeled  red  cells. 
Actual rosette formation was confirmed by light microscopy. Cells coated with 
IgG1 and IgG8 were bound to monolayers, but little adherence occurred  with 
cells coated with IgG2 and IgG4. 
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Specificity of IgG Fragment.--In  order  to  identify the  portion  of  the  IgG 
molecule which  bound  to  the  mononuclear  cell, fragments  of  IgG  were  pre- 
pared  and  tested  in  rosette-inhibition  experiments  using  anti-D-coated  red 
cells. As shown  in  Table II and  Fig. 2,  Fc inhibited rosette formation;  44% 
FIo. 1.  Binding of red cells coated with IgG subclasses to leukocyte monolayers. IgG sub- 
classes were specifically coupled by chromic chloride.  Red cells were trace-radiolabeled with 
Na~lCrO4. 
IOO 
k  40 
~  2o 
f 
0  I0  20  30  40 
mg/lO0 m/  PROTEIN 
FI6. 2.  Inhibition of rosette formation by varying concentrations of Fc of IgG globulin. 
Abscissa represents final protein concentration.  The per cent inhibition is noted on the ordinate. 
inhibition was  noted  with  as  little as 0.25  mg/100  ml  of protein.  F(ab~)2 re- 
sulted  in  15%  inhibition  whereas  no  inhibition  occurred  with  Fab  or  with 
pepsin components II, III, or IV. Altering the tertiary structure of Fc by treat- 
ment with 8 ~  urea did not affect inhibitory activity. However, the cleavage of 
disulfide bonds with DTT  in the presence of 8 M urea reversed the inhibitory 1212  INTERACTION BETWEEN  HUMAN  MONOCYTES  AND  RED  CELLS 
activity of Fc. Purified heavy chains from the urine of a patient with 71 heavy 
chain disease resulted in 86.6% inhibition. Treatment of 71 heavy chain with 
8 •  urea did not destroy inhibitor)' activity but,  with DTT in  8 u  urea,  in- 
hibition was decreased significantly (30.8 % inhibition). 
C3 Receptor  for Rosette Formation.--Rosette formation was tested with three 
types of C3-coated red cells.  Complement was  "fixed" to red cells  with anti- 
Duffy, anti-Kidd,  anti-H,  or anti-I isoantibodies and the antibody was  then 
removed by incubation  and  washing.  The red  cells  did  not  agglutinate  and 
were negative with anti-IgG Coombs reagent. They were positive with anti-C3 
Coombs reagent, indicating a coating with C3. No binding to or phagocytosis 
of such red cells was noted with human monocytes. However, when antibody 
was  incompletely  removed,  rosette  formation  and  occasional  phagocytosis 
could be observed. Secondly, red  cells which  were coated with  C3  (and  C4) 
by suspension in low ionic strength sucrose medium were not bound to mono- 
cytes. Finally, red cells coated with C3 spontaneously in vivo from a patient 
lacking the C3 inactivator (17) failed to form rosettes with human monocytes 
and polymorphonuclear leukocytes. 
DISCUSSION 
The Fc fragment mediates several  biologic functions  of IgG globulin,  in- 
cluding  complement  fixation,  placenta]  transfer,  immune  adherence,  and 
fixation  to  skin  receptors  in  passive  cutaneous  anaphylaxis.  Some  of  these 
properties of Fc fragments  are  associated  with  selective IgG  subclasses  (6). 
IgG subclass specificity has been associated with yet another biologic function 
of Fc,  namely  binding  to monocytes.  Rosette formation by monocytes and 
anti-D-coated red cells can be inhibited by purified IgG myeloma proteins of 
subclasses  1 and 3.  These results are consistent with  observations on the in- 
hibition of phagocytosis of anti-D-coated red cells (18). Since anti-D antibody 
is'reported  to be  composed of IgG1  and  IgG3  molecules  (19),  the inhibition 
of rosette formation by free IgG1 and IgG3 does not by itself indicate the se- 
lectivity of the  receptor site  for  these  antibody subclasses.  However,  when 
myeloma proteins of the various IgG subclasses were individually coupled to 
red cells, cells coated with IgGl and IgG3 formed rosettes, whereas those coated 
with IgG2 and IgG4 did not. Rosette-inhibition experiments using heavy chains 
isolated from patients with heavy chain disease confirm the specificity of heavy 
chains of "h and 71,3. 
In order to delineate further the peptide region of gamma globulin responsible 
for  binding  to  monocytes,  several  enzymatically  produced  peptides  were 
studied  for  their  capacity to  inhibit  rosette formation.  (Fab~)2 was  slightly 
inhibitory, whereas Fab fragments did not inhibit rosette formation. This small 
difference between (Fab')2 and Fab suggested that the attachment of anti-D- 
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of the inter-heavy chain disulfide bond. This is consistent with the report that 
(Fab~)2 of anti-D, when attached to red ce]ls, formed rosettes, although not as 
effectively as with intact anti-D  (18). Pepsin component II, a  noncovalently 
linked dimer of 116  amino  acids  of the  C-terminal end  of IgG,  and  smaller 
peptides,  components III and IV,  all  failed to inhibit rosette formation. 
When the disulfide bonds of Fc fragment or 3'1 heavy chain,  isolated from 
the urine of a  patient with heavy chain disease,  were reduced and  alkylated 
to yield single  chains  of Fc or  3'1 heavy chains,  respectively, inhibition was 
abolished. Loss of inhibitory activity appeared not to be due to an alteration 
of tertiary structure since Fc and 3'1 heavy chains which were treated with 8 M 
urea retained full inhibitory activity. These studies suggested that the binding 
of IgG to the mononuclear cell occurred near the N-terminal end of the Fc 
portion  of the molecule. In  addition,  inhibitory activity appeared  to be de- 
pendent on the integrity of the inter-heavy chain disulfide bond. This observa- 
tion is in accord with the findings of others working with complement fixation 
and passive cutaneous anaphylaxis (20,  21). An alternate explanation is that 
reduction of intra-heavy chain disulfide bonds by DTT-induced conformational 
changes in the molecule which may have affected binding. 
The monocyte receptor  appeared  to  be  somewhat  more  specific for  IgG3 
than for the other subclasses of IgG,  as judged by rosette inhibition (at low 
protein  c~ncentrations)  and  chromic  chloride  coupling  experiments.  Heavy 
chains of 3"3 were slightly less  effective than intact IgG3  in rosette-inhibition 
experiments (Tables I and II). This difference may reflect the known alteration 
in the number of disulfide bonds  (22)  or some other difference in amino acid 
sequence of the 3'3 heavy chain in this unusual disease. 
Recently, a  monocyte receptor for C3 has been reported (4)  in a  study in 
which  heterologous  antisera  were  used  and  enhancement  of  phagocytosis 
rather than rosette formation was described. In the experiments reported here, 
when C3 was "fixed" to cells by isoantibodies or aggregated to cells by suspen- 
sion in low ionic sucrose medium, the red cells did not attach to mononuclear 
cells.  In  addition,  the  C3-coated cells  from a  patient deficient in the  C3  in- 
activator  (17)  did  not  adhere  to mononuclear cells.  IgM  agglutinins  in  the 
presence of complement have been observed to form mixed aggregates  (12), 
but red cells coated only with C3 did not adhere to monocytes. Cell-bound C3 
may possess peptidase activity (23), which appears to be critical for the medi- 
ation  of phagocytosis (24).  It is possible that  C3  enhances phagocytosis not 
because of a specific cellular receptor but rather because of the peptidase ac- 
tivity  of  activated  C3.  In  this  regard,  LoBuglio  (25)  has  recently demon- 
strated enhanced rosette formation by pretreatment of monocytes with various 
proteolytic enzymes. 
Red cells  coated with warm antibodies in some patients  may survive nor- 
mally,  whereas  in  others  a  striking  spherocytic  hemolytic  anemia  occurs. 1214  INTERACTION  BETWEEN HUMAN MONOCYTES AND RED  CELLS 
This difference and its relationship to subclass  specificity of these antibodies is 
unknown. Perhaps the genetic or antigenic factors which direct the formation 
of the  specific  subclass  of antibody may be  important  in  determining  which 
Coombs positive red cells  will be altered  in  vivo  and which will survive nor- 
mally. 
SUMMARY 
Studies were carried out in  order to characterize the specificity of IgG sub- 
classes  and  IgG fragments  for  rosette  formation  using  red  cells  and  human 
mononuclear cells.  Rosette formation of red  cells  coated with  anti-D  was in- 
hibited  by free IgG1 and  IgG3;  less  inhibition  occurred with  IgG2  and  IgG4. 
Red  cells  specifically  coated  with  IgG1  and  IgG3 by  chromic  chloride  were 
bound  to  monocytes. Rosette  inhibition  of  anti-D-coated red  cells  occurred 
with free Fc fragment of IgG globulin, and only partly with F(ab')2. Inhibitory 
capacity of Fc fragments of IgG and ~/1 heavy chain from heavy chain disease 
was reversed by the cleavage of disulfide  bonds. No inhibition was noted with 
Fab,  or with pepsin  components II, III, or IV.  These  studies  indicated  that 
the mononuc]ear receptor was specific for IgG1 and IgGs. The peptide portion 
of IgG globulin which attached to the mononuclear cell appeared to reside  in 
the N-terminal portion of the Fc fragment and  also  appeared  to require  the 
integrity  of the  inter-heavy chain  disulfide  bond.  A  specific  receptor  for  C3 
was not confirmed. 
We are indebted to Dr. Ezio Merler for his expert advice, to Miss Deborah Felmlee for 
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